nivolumab
bms
['nadim ii', 'nadim', 'lcsm,(-blcsm)']
nadim ii: the neo-adjuvant chemoio evidence builds &amp; builds. chemoimmunotherapy should now be the standard of care in the treatment of this disease #lcsm #asco22 
Thoracic medical oncologist | Consultant @ChelwestFT | Vice Chair @BTOGorg | Skier, when snow permits.